Abstract. TRAIL has been reported to induce apoptosis in a variety of tumor cell types including hepato-cellular carcinoma (HCC) cell lines. However, considerable numbers of HCC cells, especially some highly malignant tumors, show resistance to TRAIL-induced apoptosis. The molecular mechanisms that regulate sensitivity versus resistance of tumor cells to TRAIL-induced apoptosis remain poorly defined. It has been shown that human telomerase catalytic subunit (hTERT) is overexpressed in human HCCs. In this study, we investigated the effects and the mechanisms of hTERT RNAi on the TRAIL-induced apoptosis of HCC cells that exhibit resistance to TRAIL. Our results indicate that hTERT RNAi sensitizes TRAIL-resistant HCC cells to TRAIL-induced apoptosis. hTERT RNAi-mediated sensitization to TRAIL-induced apoptosis is accompanied upregulation of procaspases-8 and -9, inhibition of telomerase activity and loss of telomere length. Our results suggest that hTERT RNAi overcame the resistance of the HCC cells against TRAIL, at least in part, via the mitochondrial type II apoptosis pathway and telomerase-dependent pathway.
Introduction
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a potential anticancer agent (1) . However, considerable numbers of cancer cells, especially some highly malignant tumors, are resistant to apoptosis induced by TRAIL, and some cancer cells that were originally sensitive to TRAIL-induced apoptosis can become resistant after repeated exposure (acquired resistance). Understanding the mechanisms underlying such resistance and developing strategies to overcome it are important for the successful use of TRAIL for cancer therapy (2) .
Human telomerase is a ribonucleoprotein composed of human telomerase RNA component (hTR) (3) , human telomerase catalytic subunit (hTERT) (4) and TEP1, a telomeraseassociated protein (5) . There is a strong correlation between the presence of hTERT mRNA and telomerase activity and it is recognized that hTERT is the rate-limiting determinant of the enzymatic activity of human telomerase (4, 6, 7) . The expression of hTERT mRNA is detected at high levels in tumor tissues and tumor-derived cell lines but not in normal adjacent tissues or primary cells (8) (9) (10) (11) (12) . Owing to this differential expression pattern in normal and tumors cells, hTERT has been proposed as a promising target for anticancer therapies.
Hepatocellular carcinomas (HCCs) are drug-resistant tumors that frequently possess high telomerase activity. Reactivation of telomerase activity is a characteristic molecular mechanism in hepatocarcinogenesis and it has been shown that hTERT is overexpressed in 80-100% of human HCCs (12) (13) (14) . The effect of hTERT RNAi on the induction of apoptosis in TRAIL-resistant HCC cell lines is poorly understood. It was therefore the aim of this study to investigate the effect and the mechanisms of hTERT RNAi on the TRAILinduced apoptosis of HCC cells. We firstly constructed eukaryotic expression plasmid of hTERT RNAi, then transfected it into the human HCC cell lines Huh7 and Hep3B, examined cellular apoptosis, apoptosis-associated protein expression, telomerase activity and telomere length in transfected HCC cells. Our data show that hTERT RNAi increase procaspase-8 and -9 expression, inhibit telomerase activity and shorten telomere length, which accounts for the sensitization to TRAIL-induced apoptosis.
Materials and methods

Construction of eukaryotic expression vector of hTERT RNAi.
We introduced hTERT sequence from nucleotides 3114-3134, followed by 9 bp to form a loop and the corresponding antisense hTERT nucleotides, followed by six uridines into pSilencer 3.1-H1 neo vector (Ambion, USA). The sequences used for the hairpin were: forward, 5'-GATCCGTTT CATCAGCAAGTTTGGATTCAAGAGATCCAAACTTG Cell culture and transfection. The human HCC cell lines Huh7 and Hep3B were obtained from American Type Culture Collection. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Hyclone, USA) supplemented with 10% FCS, 100 U/ml penicillin, and 100 g/ml streptomycin, and were maintained in a humidified atmosphere of 95% air and 5% CO 2 at 37˚C. Huh7 and Hep3B cells were stably transfected using transfection reagent DOGS (Ambion) with pSilencer 3.1-H1 neo-shTERT or pSilencer 3.1-H1 neo negative control plasmids (Ambion). The former was the transfected group and the latter the control group.
Identification of interference sequences.
As the recombinant plasmid, we also applied the universal primers of M13(-40) and 3.0 rev to confirm the interference sequences of transfection and control cells. The size of amplification product would be 327 bp in transfected cells, 324 bp in control cells.
Reverse transcription-PCR (RT-PCR).
RT-PCR was performed to detect mRNA expression of hTERT and glyceraldehyde phosphate dehydrogenase (GAPDH) as described (16) . hTERT was amplified using the primer pair 5'-CGG AAG AGT GTC TGG AGC AA-3' (LT5) and 5'-CTC AGA CAC CAT GGG GAA GGT GA-3' (LT6) for 35 cycles (94˚C for 45 sec, 60˚C for 45 sec and 72˚C for 90 sec). GAPDH was amplified using primers 5'-CTC AGA CAC CAT GGG GAA GGT GA-3' (K136) and 5'-ATG ATC TTG AGG CTG TTG TCA TA-3' (K137) for 20 cycles (94˚C for 45 sec, 60˚C for 45 sec and 72˚C for 90 sec). Amplification products were then resolved on 12% nondenaturing polyacrylamide gel. hTERT interference rate (%) was [1- Telomerase activity and telomere length detection. Telomerase activity was measured by telomeric repeat amplification protocol (TRAP) as described previously (17) . Mean telomere length was measured using solution hybridizationbased method named as telomere amount and length assay (TALA) as described previously (18, 19) . Results were all repeated twice.
Western blot analysis. Cells in culture were harvested and lysed in T-PER Tissue Protein Extraction. The lysed cells were centrifuged at 18,000 x g for 15 min. Protein concentrations of the cell extracts were measured by Lowry's method. Proteins (50 μg) were separated by PAGE under reducing conditions, transferred onto PVDF membranes (Pierce, USA) and detected with enhanced chemiluminescence (ECL) reagents (Pierce). The following antibodies were used: caspase-8 (Cell Signaling, USA), caspase-9, caspase-3, Bcl-2, Bax and Actin (Santa Cruz, USA). Secondary horseradish peroxidase-conjugated goat anti-mouse, goat anti-rat and goat anti-rabbit antibodies were used.
Data analysis. Band intensions of RT-PCR experiments were evaluated densitometrically using Quantity One analysis software (Bio-Rad). For statistical analysis, data were subjected to one-way or two-way ANOVA using SPSS 11.5 for Windows (SPSS, USA). Differences between experimental groups were determined by F test. Differences were considered statistically significant at P<0.05.
Results
Identification of recombinant plasmid and interference sequence. PCR amplified product of pSilencer 3.1-HI neoshTERT was 327 bp. After restriction with enzymes, the product with single enzyme resection was 4288 bp and that with paired enzyme resection was 4224 bp and 64 bp. Combined with the result of DNA sequencing, it revealed that the sequence of inserted shTERT was correct (Fig. 1A ). Huh7 and Hep3B cells were transfected with recombinant and control plasmids. The cell clones were selected and genomic DNA was extracted. DNA of the recombinant plasmids served as positive control and DNA of untransfection cells as negative control. The results of PCR amplification are shown (Fig. 1B) . Amplified products were found in 6/8 clones of Huh7 cells and in 6/6 clones of Hep3B cells and they were preserved for next experiments. hTERT RNAi sensitizes resistant HCC cells for TRAIL-induced apoptosis. We examined effect of hTERT RNAi on TRAILinduced apoptosis in human HCC cell lines Huh-7 and Hep3B at different concentrations. Our results showed that TRAIL was unable to induce apoptosis effectively in the two types of cells even at the concentration up to 100 ng/ml (<15%). However, hTERT RNAi reversed the resistance to TRAIL in two cell lines and induced significant apoptosis in a dosedependent manner, which was far higher than that of the untransfected and control cells (P<0.05). However, there was no obvious effect on control and untranfected cells (Fig. 3) . Western blot analysis showed that cleavage of the proenzymes into the active fragments of caspase-8, -9 and -3 was only found in transfected cells treated with TRAIL but not in untransfected and control cells (Fig. 4) . This suggests that the mitochondrial type II apoptosis pathway contributes to the hTERT RNAi-mediated sensitization to TRAIL-induced apoptosis.
hTERT RNAi up-regulates the expression of procaspase-8, -9, and Bcl-2, and down-regulates the expression of Bax in resistant HCC cells. Expression of apoptosis-associated proteins were detected with Western blot analysis (Fig. 5) . hTERT RNAi obviously increased the expression of procaspase-8, -9, and Bcl-2 (P<0.05) and decreased the expression of Bax in resistance HCC cells (P<0.05). However, expression of procaspase-3 was not notably different compared with untransfected and control cells (P>0.05).
hTERT RNAi inhibits telomerase activity in resistant HCC cells. Telomerase activities were detected with TRAP method (Fig. 6A) . Compared with untransfected cells and control cells, transfected cells showed obviously decreased telomerase activities. Statistical analysis indicated that hTERT RNAi significantly decreased telomerase activities of transfected cells (P<0.05), but there were no obvious differences between untransfected and control cells (P>0.05).
hTERT RNAi significantly decreased telomere length in resistant HCC cells. Telomere length was detected with TALA method (Fig. 6B) . In Huh7 cells, compared with untransfected cells, telomere length increased 2.057% in control cells, but decreased 13.29% in transfected cells. In Hep3B cells, contrast to untransfected cells, telomere length increased 1.646% in control cells. However, telomere length could not be detected in transfected cells for its telomere disappeared. Statistical analysis revealed that hTERT RNAi significantly decreased telomere length of transfected cells (P<0.05), but there were no obvious differences between untransfected and control cells (P>0.05).
Discussion
Although TRAIL is a potent inducer of apoptosis in cancer cells, there are still several TRAIL-resistant cancer cells. Many successful approaches have been deviced to overcome this resistance, such as the combination of TRAIL with reagents such as DNA damaging agents (20, 21) , ionizing radiation (22), or virus expressing wild-type p53 (23) . In this study, we tested the effect of hTERT RNAi on the TRAIL-induced apoptosis in TRAIL-resistant HCC cell lines. We found that hTERT RNAi can sensitize TRAIL-resistant HCC cells to TRAILinduced apoptosis, suggesting that hTERT may be a suitable target molecule for drug-resistant HCCs.
Although TRAIL has been reported to induce apoptosis in a variety of tumor cell types including HCC cell lines (24) , the molecular mechanisms that regulate sensitivity versus resistance of HCC cells to TRAIL-induced apoptosis remain poorly defined. Two main signaling pathways have been delineated to initiate the apoptosis in mammalian cells, the extrinsic and intrinsic pathways (25) . The extrinsic pathway Figure 3 . Effects of hTERT RNAi on TRAIL-induced apoptosis. TRAIL was unable to induce apoptosis effectively in the two types of cells even at the concentration up to 100 ng/ml (<15%). However, hTERT RNAi reversed the resistance to TRAIL in two cell lines and induced significant apoptosis in a dose-dependent manner.
can be initiated by members of the TNF superfamily, which later leads to activation of caspase-8 (26) . TRAIL triggers apoptosis through interaction with their death receptors DR4/DR5 and subsequent recruitment of intra-cellular adaptor Fas-associated death domain (FADD) (27) . FADD in turn recruits caspase-8 through interaction of their death effector domains (DED), leading to the assembly of deathinducing signaling complex (DISC) (28) .
In the DISC, caspase-8 is cleaved and activated through autoproteolysis (29) and subsequently cleaves caspase-3 (30) and Bcl-2 inhibitory BH3-domainprotein (Bid) (31) . The truncated Bid interacts with Bax and Bak and induces mitochondrial release of cytochrome c into the cytosol (32) in which caspase-9 is activated and cleaves caspase-3 (33) . Caspase-3 in turn cleaves its substrates such as DNA fragmentation factor 45 (DFF45), leading to apoptosis (34) . Accordingly, our results showed that the cleavage of proenzymes into the active fragments of caspase-8, -9 and -3 was only found in transfected cells treated with TRAIL, but not in untransfected and control cells, and thus enhancing procaspase-8, and -9 expression. These results indicate the importance of intrinsic mitochondria pathway in hTERT RNAi mediated TRAIL-induced apoptotic cell death. However, procaspase-3 did not correspondingly increase. The mechanism is unknown and may be involved in augmenting cell apoptosis and accentuation of procaspase-3 cleavage in HCC cells with hTERT RNAi.
Bcl-2 family proteins play important roles in regulating mitochondrial permeabilization and activation of caspases, and are classified as two groups in this family, anti-apoptotic members (e.g. Bcl-2 and Bcl-xL) and pro-apoptotic members (e.g. Bid and Bcl-xS) (35) . The Bcl-2 family of proteins regulates apoptosis and it has been demonstrated that the gene products of Bcl-2 and Bax play important roles in apoptotic cell death (36) . In this study, an increase in the level of proapoptotic protein Bax with a decrease in level of anti-apoptotic protein Bcl-2 was observed in hTERT RNAi TRAIL-resistant HCC cells, suggesting that Bcl-2 family proteins may be involved in hTERT RNAi mediated TRAILinduced apoptotic cell death. Telomerase activation is one of the critical steps in malignant transformation. It contributes to installing an immortal cell phenotype by preventing apoptosis, and may play a role in cellular resistance to anticancer drugs (37) (38) (39) . Although telomerase is a complex composed of hTR, hTERT and TEP1, telomerase activity is mainly transcriptionally controlled by the hTERT promoter (40) . It has been shown that telomerase is strongly activated in the majority of HCCs and the degree of telomerase activation correlates with histologic dedifferentiation of the tumors (41), providing a precondition for effective telomerase-dependent therapy. Moreover, the sensitivity of tumor cells to chemotherapy and radiotherapy significantly increase after telomere erosion and telomerase activity drop (42) . In this study, we found that hTERT RNAi resulted in inhibition of telomerase, telomere erosion, and enhanced the cytotoxicity of TRAIL in TRAILresistant HCC cells. These results indicat that hTERT RNAi mediated TRAIL-induced apoptosis may be related to inhibition of telomerase and erosion of telomere.
In conclusion, our results indicate that hTERT RNAi sensitizes TRAIL-resistant HCC cells to TRAIL-induced apoptosis. hTERT RNAi-mediated sensitization to TRAILinduced apoptosis is accompanied up-regulation of procaspase -8, and -9, inhibition of telomerase activity and erosion of telomere length, suggesting that hTERT RNAi overcame the resistance of the HCC cells against TRAIL, at least in part, via intrinsic pathway and telomerase-dependent pathway.
